EUVIMEDEUVIMED entdecken
Crossref

A Noninvasive and Highly Effective Inhaled Nanovaccine Based on Natural Polysaccharide for Lung Cancer Treatment

Qiang Zhang, Yu Miao, Zhike Chen, Yi Liu, Linfu Chen, Zhisheng Xiao, Hui Shen, Jingjing Shen, Feng Pan, Nanhui Liu, Xinying Lv, Haibin Zhao und 4 weitere

Advanced Materials · 2025-10 · 37 (42)

DOI: 10.1002/adma.202504987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 02.08.2025. Verfasst von Qiang Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Cancer Vaccines, Nanoparticles, Polysaccharides. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Research Programs of China, National Natural Science Foundation of China, Shanghai Academic Research Leader.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is the most widespread malignancy globally and the leading cause of cancer‐related deaths, highlighting the need for innovative treatments. Herein, a novel inhaled vaccine carrier is presented by modifying dextran (Dex) with N , N ‐dimethylethylenediamine (DMEN) and 4‐(bromomethyl)phenylboronic acid (PBA) (Dex–DMEN–PBA, DDP). The optimized DDP demonstrates a potent adjuvant effect in promoting dendritic cell (DC) maturation by multiple signaling pathways. Moreover, the nanovaccine (DDP/Lewis lung carcinoma (LLC)) forms through electrostatic interactions between DDP and protein antigens derived from LLC cells. Upon inhalation, it induces DC maturation, T cell activation, and germinal center B cell activation in the thoracic lymph node. In the mouse model, the inhaled DDP/LLC nanovaccine displays impressive prophylactic effects against lung cancer, with 50% of mice alive after six months and 33% surviving a subsequent challenge, indicating strong long‐term immune memory. Remarkably, it surpasses subcutaneous vaccination, particularly in activating germinal center B cells and follicular helper T (Tfh) cells, and upregulating tissue‐resident memory T (T RM ) cells in the lung. This self‐adjuvant nanovaccine effectively prevents tumor growth and induces robust immune memory, offering valuable insight for treating lung cancer and related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCancer VaccinesNanoparticlesPolysaccharidesAnimalsMiceAdministration, InhalationMice, Inbred C57BLDendritic CellsCarcinoma, Lewis LungDextransCell Line, TumorBoronic AcidsNanovaccines

Stichwörter der Autor:innen

lung cancernatural polysaccharidenoninvasive nanovaccinephenylboronic acid

Substanzen

Cancer VaccinesDextransPolysaccharidesBoronic AcidsNanovaccines

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China.
  • School of Materials Science and Engineering, Tongji University, Shanghai, 201804, China.
  • Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou, 215123, China.
  • Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
  • Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200086, China.
  • Innovation and Incubation Center, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China.

ORCID-Profile: Qian Chen, Yang Yang

Förderung

  • National Research Programs of China
  • National Natural Science Foundation of China
  • Shanghai Academic Research Leader
  • Natural Science Foundation of Jiangsu Province
  • Program of Shanghai Academic Research Leader

Zitieren

APA

Zhang, Q., Miao, Y., Chen, Z., Liu, Y., Chen, L., Xiao, Z., Shen, H., Shen, J., Pan, F., Liu, N., Lv, X., Zhao, H., Yu, Q., Zheng, Z., Chen, Q., & Yang, Y. (2025). A Noninvasive and Highly Effective Inhaled Nanovaccine Based on Natural Polysaccharide for Lung Cancer Treatment. Advanced Materials, 37(42). https://doi.org/10.1002/adma.202504987

Vancouver

Zhang Q, Miao Y, Chen Z, Liu Y, Chen L, Xiao Z, et al. A Noninvasive and Highly Effective Inhaled Nanovaccine Based on Natural Polysaccharide for Lung Cancer Treatment. Advanced Materials. 2025;37(42). doi:10.1002/adma.202504987

BibTeX
@article{Zhang2025,
  author = {Zhang, Qiang and Miao, Yu and Chen, Zhike and Liu, Yi and Chen, Linfu and Xiao, Zhisheng and Shen, Hui and Shen, Jingjing and Pan, Feng and Liu, Nanhui and Lv, Xinying and Zhao, Haibin and Yu, Qifan and Zheng, Zixuan and Chen, Qian and Yang, Yang},
  title = {A Noninvasive and Highly Effective Inhaled Nanovaccine Based on Natural Polysaccharide for Lung Cancer Treatment},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {42},
  doi = {10.1002/adma.202504987}
}
Kostenlos starten →